Postal Ballot: Approval for NCD Issuance up to Rs 2,500 crore
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova seeks shareholder approval via postal ballot to issue secured or unsecured, listed, rated, redeemable Non-Convertible Debentures on a private placement basis for up to Rs 2,500 crore, in one or more series over one year. Issuance stays within the existing Rs 5,000 crore overall borrowing limit and will not dilute equity. E-voting runs Oct 22 to Nov 20, 2026. Funds targeted at capex, refinancing, working capital, investments, and general corporate purposes.
Non-dilutive debt raise authority within existing borrowing limits. Awaiting shareholder vote outcome by Nov 20, 2026.